HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life.

AbstractOBJECTIVE:
An increased dose of the prescribed drug or a change of the drug is recommended in the treatment for the patients with urticaria refractory to the standard dose of antihistamines. Efficacy and safety of doubling the dose of cetirizine were compared with olopatadine in the patients with symptoms like wheal or itching, despite the treatment with the standard dose of cetirizine.
METHODS:
Cetirizine was administered at 10 mg once daily to 51 patients with urticaria for a mean of 10.1 ± 7.3 days (period A). Patients with inadequate responses were randomized to either cetirizine 20 mg once daily (dose-increase group) or olopatadine 5 mg twice daily (drug-change group) for a mean of 13.3 ± 8.3 days (Period B). The severity of wheal and itching, and the quality of life (QOL) measured by Skindex-16 were evaluated.
RESULTS:
In period A, an adequate response was obtained in 64.7% (33/51). Nine patients each with inadequate response were randomized to either the drug-change or dose-increase groups. A significant improvement was observed in the severity of wheal and itching in the dose-increase group in period B. The QOL was significantly improved in all sub-scales of Skindex-16.
CONCLUSION:
Doubling the dose of cetirizine may be efficacious to the patients with urticaria refractory to the regular dose of cetirizine.
AuthorsYukari Okubo, Yukie Shigoka, Masashi Yamazaki, Ryoji Tsuboi
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 24 Issue 2 Pg. 153-60 (Apr 2013) ISSN: 1471-1753 [Electronic] England
PMID21810005 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Allergic Agents
  • Dibenzoxepins
  • Histamine H1 Antagonists, Non-Sedating
  • Olopatadine Hydrochloride
  • Cetirizine
Topics
  • Adolescent
  • Adult
  • Anti-Allergic Agents (administration & dosage, adverse effects)
  • Cetirizine (administration & dosage, adverse effects)
  • Dibenzoxepins (administration & dosage, adverse effects)
  • Double-Blind Method
  • Female
  • Histamine H1 Antagonists, Non-Sedating (administration & dosage, adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Olopatadine Hydrochloride
  • Prospective Studies
  • Pruritus (drug therapy)
  • Quality of Life (psychology)
  • Treatment Outcome
  • Urticaria (drug therapy, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: